Document Detail


Cannabis use and oral diseases.
MedLine Citation:
PMID:  21701541     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Data sourcesMedline and the Cochrane Central register of controlled trails (CENTRAL).Study selectionRandomised Controlled Trials, Controlled Clinical Trials and Cohort Studies conducted on humans investigating cannabis usage were included. Screening was performed independently by two reviewers. Only English language studies were included. Case reports, letters and historical reviews were excluded.Data extraction and synthesisA narrative synthesis was conducted.ResultsSeven studies were included and a range of cannabis-associated oral side effects identified.ConclusionsBased on the limited data, it seems justified to conclude that with increasing prevalence of cannabis use, oral health care providers should be aware of cannabis-associated oral side effects such as xerostomia, leukoedema and an increased prevalence and density of Candida albicans.
Authors:
Analia Veitz-Keenan; Silvia Spivakovsky
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Evidence-based dentistry     Volume:  12     ISSN:  1476-5446     ISO Abbreviation:  Evid Based Dent     Publication Date:  2011  
Date Detail:
Created Date:  2011-06-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883603     Medline TA:  Evid Based Dent     Country:  England    
Other Details:
Languages:  eng     Pagination:  38     Citation Subset:  D; IM    
Affiliation:
NYU College of Dentistry, New York, USA and PEARL Network Practitioners, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnostic accuracy studies needed for cone beam computed tomography.
Next Document:  Limited evidence of the effect of chlorhexidine varnish (CHX-V) on root caries.